Patrycja Gazinska

Summary

Affiliation: King's College London
Country: UK

Publications

  1. pmc Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control
    Emanuele De Rinaldis
    Breakthrough Breast Cancer Research Unit, Division of Cancer Studies, School of Medicine, King s College London, Guy s Hospital, London, UK
    BMC Genomics 14:643. 2013
  2. pmc Comparative immunohistochemical analysis of ochratoxin A tumourigenesis in rats and urinary tract carcinoma in humans; mechanistic significance of p-S6 ribosomal protein expression
    Patrycja Gazinska
    Breakthrough Breast Cancer Research Unit, Guy s Hospital, King s Health Partners AHSC, King s College London School of Medicine, London SE1 9RT, UK
    Toxins (Basel) 4:643-62. 2012
  3. pmc Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value
    Shalaka Joshi
    Department of Research Oncology, King s College London, Faculty of Life Science and Medicine, Division of Cancer Studies, Bermondsey Wing, Guy s Hospital, London, UK
    BMC Cancer 15:546. 2015
  4. pmc Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers
    Johnathan Watkins
    Breakthrough Breast Cancer Research Unit, King s College London, London, United Kingdom Institute for Mathematical and Molecular Biomedicine, King s College London, London, United Kingdom Department of Research Oncology, King s Health Partners AHSC, Life Sciences and Medicine, King s College London, London, United Kingdom
    Cancer Discov 5:488-505. 2015

Collaborators

  • Alan Ashworth
  • Peter Mantle
  • Johnathan Watkins
  • Shalaka Joshi
  • Anita Grigoriadis
  • Sarah Pinder
  • Cheryl Gillett
  • Emanuele De Rinaldis
  • Melinda L Telli
  • Anders Isaksson
  • Christopher J Lord
  • Sarah E Pinder
  • Shaveta Vinayak
  • James M Ford
  • Maggie C U Cheang
  • Vandna Shah
  • Daniel Weekes
  • Fabio Vanoli
  • John P Brown
  • Bhavna Sidhu
  • Markus Mayrhofer
  • Maria Jasin
  • Andrew N J Tutt
  • Cheryl E Gillett
  • Jessica Frankum
  • Hasan Mirza
  • David Dornan
  • Anca Mera
  • Andrew Tutt
  • Zora Modrusan
  • Brian Burford
  • Pierfrancesco Marra
  • Lars Holmberg
  • Grazyna M Fedorowicz

Detail Information

Publications4

  1. pmc Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control
    Emanuele De Rinaldis
    Breakthrough Breast Cancer Research Unit, Division of Cancer Studies, School of Medicine, King s College London, Guy s Hospital, London, UK
    BMC Genomics 14:643. 2013
    ....
  2. pmc Comparative immunohistochemical analysis of ochratoxin A tumourigenesis in rats and urinary tract carcinoma in humans; mechanistic significance of p-S6 ribosomal protein expression
    Patrycja Gazinska
    Breakthrough Breast Cancer Research Unit, Guy s Hospital, King s Health Partners AHSC, King s College London School of Medicine, London SE1 9RT, UK
    Toxins (Basel) 4:643-62. 2012
    ....
  3. pmc Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value
    Shalaka Joshi
    Department of Research Oncology, King s College London, Faculty of Life Science and Medicine, Division of Cancer Studies, Bermondsey Wing, Guy s Hospital, London, UK
    BMC Cancer 15:546. 2015
    ..Even for Ki67, one of the most widely-studied markers, disagreements over the optimal cutoff exist. Improvements in digital microscopy may provide new avenues to standardise and make data more reproducible...
  4. pmc Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers
    Johnathan Watkins
    Breakthrough Breast Cancer Research Unit, King s College London, London, United Kingdom Institute for Mathematical and Molecular Biomedicine, King s College London, London, United Kingdom Department of Research Oncology, King s Health Partners AHSC, Life Sciences and Medicine, King s College London, London, United Kingdom
    Cancer Discov 5:488-505. 2015
    ..Our data therefore provide a mechanistic association between HORMAD1 expression, a specific pattern of genomic instability, and an association with response to platinum-based chemotherapy in TNBC...